fig1
![Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement (TAVR): from current evidence to perspective](https://image.oaes.cc/69ea3d03-e552-420f-bcd8-bd72613a0133/5132.fig.1.jpg)
Figure 1. History of indications to TAVR: from prohibitive to low-intermediate risk.
Figure 1. History of indications to TAVR: from prohibitive to low-intermediate risk.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/